000 | 01943 a2200577 4500 | ||
---|---|---|---|
005 | 20250516225056.0 | ||
264 | 0 | _c20141111 | |
008 | 201411s 0 0 eng d | ||
022 | _a1872-8421 | ||
024 | 7 |
_a10.1016/j.jneuroim.2014.07.011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMoon, Jangsup | |
245 | 0 | 0 |
_aNon-stiff anti-amphiphysin syndrome: clinical manifestations and outcome after immunotherapy. _h[electronic resource] |
260 |
_bJournal of neuroimmunology _cSep 2014 |
||
300 |
_a209-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
650 | 0 | 4 |
_aAutoantibodies _xblood |
650 | 0 | 4 |
_aCerebellar Diseases _xdrug therapy |
650 | 0 | 4 |
_aEncephalomyelitis _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
650 | 0 | 4 |
_aLimbic Encephalitis _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
650 | 0 | 4 |
_aNerve Tissue Proteins _ximmunology |
650 | 0 | 4 |
_aPrimary Dysautonomias _xdrug therapy |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 |
_aStiff-Person Syndrome _xdrug therapy |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLee, Soon-Tae | |
700 | 1 | _aShin, Jung-Won | |
700 | 1 | _aByun, Jung-Ick | |
700 | 1 | _aLim, Jung-Ah | |
700 | 1 | _aShin, Yong-Won | |
700 | 1 | _aKim, Tae-Joon | |
700 | 1 | _aLee, Keon-Joo | |
700 | 1 | _aPark, Kyung-Il | |
700 | 1 | _aJung, Keun-Hwa | |
700 | 1 | _aJung, Ki-Young | |
700 | 1 | _aLee, Sang Kun | |
700 | 1 | _aChu, Kon | |
773 | 0 |
_tJournal of neuroimmunology _gvol. 274 _gno. 1-2 _gp. 209-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jneuroim.2014.07.011 _zAvailable from publisher's website |
999 |
_c24066143 _d24066143 |